| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. (DYN) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. DYN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 5.28M | $136.53M | - | |
| Dir | 4.10M | $106.08M | - | |
| CEO | 368.2K | $9.53M | - | |
| Other | 169.2K | $4.38M | - | |
| Other | 154.2K | $3.99M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | Farwell Wildon55 | Chief Medical Officer | Sell | 9,921 | $25.86 | $256,584.60 | -3.1% | +24.4% | -53.1% | |
| Mar 7, 2024 | Scalzo Richard William58 | SVP, Head Of Finance &Admin. | Sell | 2,273 | $25.85 | $58,757.05 | -1.8% | +24.4% | -53.1% | |
| Mar 7, 2024 | McNeill Jonathan55 | Chief Business Officer | Sell | 2,434 | $25.85 | $62,918.90 | -1.7% | +24.4% | -53.1% | |
| Mar 7, 2024 | Brumm Joshua T54 | CEO &President | Sell | 9,086 | $25.85 | $234,873.10 | -1.6% | +24.4% | -53.1% | |
| Mar 7, 2024 | High Susanna Gatti66 | Chief Operating Officer | Sell | 1,591 | $25.85 | $41,127.35 | -0.8% | +24.4% | -53.1% | |
| Mar 1, 2024 | Atlas Venture Opportunity Fund I, L.P. | 10% Owner | Sell | 46,534 | $30.05 | $1,398,346.70 | -2.0% | +7.1% | -53.3% | |
| Mar 1, 2024 | Rhodes Jason P76 | Director | Sell | 46,534 | $30.05 | $1,398,346.70 | -2.0% | +7.1% | -53.3% | |
| Mar 1, 2024 | Brumm Joshua T54 | CEO &President | Sale+OE | 100,000 | $28.96 | $2,895,518.50 | -4.1% | +7.1% | -53.3% | |
| Mar 1, 2024 | McNeill Jonathan55 | Chief Business Officer | Sale+OE | 28,528 | $28.46 | $811,865.05 | -4.6% | +7.1% | -53.3% | |
| Mar 1, 2024 | Scalzo Richard William58 | SVP, Head Of Finance &Admin. | Sale+OE | 12,740 | $28.05 | $357,296.44 | -3.3% | +7.1% | -53.3% |